Posted on 23/03/202123/03/2021Lineage Cell Therapeutics Presents Additional Interim Data on OpRegen® for Dry AMD With Geographic Atrophy
Posted on 23/03/202123/03/2021Genentech Provides Update on Tominersen Program in Manifest Huntington’s Disease: Dosing to stop in Phase III clinical study of tominersen
Posted on 19/03/202119/03/2021Sarepta Therapeutics’ Investigational Gene Therapy SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Expression and Functional Improvements 2 Years After Administration
Posted on 19/03/202119/03/2021Translate Bio Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis (CF)
Posted on 16/03/202116/03/2021Solid Biosciences Reports Efficacy and Safety Data from the Ongoing IGNITE DMD Clinical Trial https://investors.solidbio.com/news-releases/news-release-details/solid-biosciences-reports-efficacy-and-safety-data-ongoing
